Fingerprint
Dive into the research topics of 'Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Hilde Marsé, Eric Van Cutsem, Axel Grothey, Sonia Valverde
Research output: Contribution to journal › Article › peer-review